Literature DB >> 25111086

Validated HPLC method for simultaneous estimation of khellol glucoside, khellin and visnagin in Ammi visnaga L. fruits and pharmaceutical preparations.

Jihan M Badr1, Ghada M Hadad, Khaled Nahriry, Hashem A Hassanean.   

Abstract

Tea bags including fruits of Ammi visnaga L. are used in Egypt as remedy for the treatment of kidney stones. Our study focuses on developing simple and rapid method utilising HPLC for quantitative estimation of khellol glucoside (KG), khellin (KH) and visnagin (VS) simultaneously. Their concentrations were determined in A. visnaga L. fruits at different developmental stages and in pharmaceutical formulations together with following up them during shelf life. Separation was accomplished using HPLC. Perfect resolution between KG, KH and VS was possible through using a mobile phase consisting of water:methanol:tetrahydrofuran (50:45:5, v/v/v). Peaks were detected at 245 nm. The suggested method for the determination of KG, KH and VS was successful in determining the analytes of interest without any interference of other compounds and matrix. All validation parameters were satisfactory and the procedure was relatively easy and fast as extracts are evaluated without previous steps of purification.

Entities:  

Keywords:  Ammi visnaga L. fruits; HPLC; khellin; khellol glucoside; visnagin

Mesh:

Substances:

Year:  2014        PMID: 25111086     DOI: 10.1080/14786419.2014.945170

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  2 in total

1.  NIPAAm-MMA nanoparticle-encapsulated visnagin ameliorates myocardial ischemia/reperfusion injury through the promotion of autophagy and the inhibition of apoptosis.

Authors:  Hairong Fu; Xiaoshan Li; Jiahua Tan
Journal:  Oncol Lett       Date:  2018-02-01       Impact factor: 2.967

Review 2.  Ammi Visnaga L., a Potential Medicinal Plant: A Review.

Authors:  Noha Khalil; Mokhtar Bishr; Samar Desouky; Osama Salama
Journal:  Molecules       Date:  2020-01-12       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.